Breaking
Saturday, June 20, 2026

Press Releases

🇪🇺 EMA Page 2

EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.

Showing 13–24 of 121 articles

High impact NewsMay 4, 2026

Novelty Nobility Expands AGC Biologics Partnership for Bispecific Antibody Manufacturing

2 min

Sofia Alvarez
High impact NewsMay 4, 2026

Smartee Denti-Technology Advances Mandibular Repositioning Technology at European Aligner Society Congress 2026

2 min

Sofia Alvarez
High impact NewsMay 2, 2026

SynbioTech Unveils Microbiome-Based Platform for Women's Healthy Aging at Vitafoods Europe 2026

2 min

Sofia Alvarez
High impact NewsMay 2, 2026

Curaleaf Appoints Torsten Greif to Board as European Medical Cannabis Market Expands

2 min

Charlotte Meyer
High impact NewsMay 2, 2026

Pharmaceutical Manufacturing Software Market to Reach $7.87 Billion by 2030, Driven by 15.8% CAGR Growth

2 min

Prof. Marcus Webb
High impact NewsMay 2, 2026

GoodRx Offers Ozempic Pill Access for Type 2 Diabetes Patients at $149 Monthly

2 min

Dr. Elena Rossi
High impact NewsMay 1, 2026

Stoke Therapeutics Zorevunersen Shows Promise for Dravet Syndrome Treatment Ahead of Q1 2026 Results

2 min

Dr. Lukas Schneider
High impact NewsMay 1, 2026

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins as Strategic Adviser for DCVax Cancer Vaccine Development

2 min

Dr. Elena Rossi
High impact NewsMay 1, 2026

Cerus Corporation INTERCEPT Blood System Advances Through European Regulatory Review and Phase 3 Trials

2 min

Matteo Ricci
High impact NewsMay 1, 2026

Bio-Rad Q1 2026 Results Show IVDR Compliance Costs Impact European Diagnostics Operations

2 min

Prof. Marcus Webb
High impact NewsMay 1, 2026

Emergent BioSolutions Reports Q1 2026 Financial Results: Biodefense Company Updates Revenue Performance

2 min

Dr. Lukas Schneider
High impact NewsMay 1, 2026

Telix Pharmaceuticals' TLX101-Px (Pixlumi) Brain Cancer Imaging Drug Accepted for European Review

2 min

Dr. Hannah O'Connor